23andMe Holding Co.
23andMe Holding Co., a pioneering leader in the personal genomics industry, is headquartered in the United States. Founded in 2006, the company has made significant strides in genetic testing and analysis, offering consumers insights into their ancestry and health through its innovative DNA testing services. With a focus on direct-to-consumer genetic testing, 23andMe provides unique products that include ancestry reports and health risk assessments, setting it apart in a competitive market. The company has achieved notable milestones, including FDA approval for certain health reports, solidifying its position as a trusted source for genetic information. Operating primarily in North America and expanding globally, 23andMe continues to lead the way in genetic research and consumer education, making it a key player in the evolving landscape of personalised medicine.
DitchCarbon Score
How does 23andMe Holding Co.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
23andMe Holding Co.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
23andMe Holding Co.'s reported carbon emissions
23andMe Holding Co., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As of now, 23andMe has not inherited any emissions data from a parent or related organization, nor does it appear to have any commitments to industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the biotechnology industry, companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific data or commitments from 23andMe, it remains unclear how the company plans to address its carbon footprint or contribute to climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
23andMe Holding Co. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
